We selected three prostate cancer cell lines with different p53 status: PC3 cells, which lack of p53 expression; LNCap cells, which express low levels of wild-type p53; and DU145 cells, which overexpress mutant p53 (Figure 1A) (Isaacs et al., 1991). Here, TP53 is linked to prostate carcinoma.